EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phosphodiesterase-5 inhibitors and testosterone in erectile dysfunction: Mechanisms, therapeutic approaches, and emerging perspectives

Vaishali Dongre, Nancy Nair, Trupti Balwir, Bhagyashree Karlekar

International Journal of Health & Allied Sciences · 2025-07 · 14 (3) · 207-213

DOI: 10.4103/ijhas.ijhas_113_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Health & Allied Sciences, online erschienen am 18.04.2026. Verfasst von Vaishali Dongre und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erectile dysfunction (ED) is a common condition with important consequences for male sexual health and fertility. Phosphodiesterase type 5 inhibitors are still the first-line treatment, although their effectiveness can be impaired in hypogonadal men. Combination therapy with testosterone replacement can improve treatment results by treating both the hormonal and vascular aspects of ED. Emerging regenerative therapies – low-intensity shockwave therapy, platelet-rich plasma, and stem cell therapy – hold potential for reversing the pathophysiology of ED, with potential curative strategies. Personalized medicine will likely become ever more important in individualizing the management of ED. A combination of lifestyle modification, pharmacologic therapy, and regenerative interventions could maximise outcomes, especially in refractory patients. Further research is necessary to confirm novel therapies and establish individualized treatment protocols.

Zitieren

APA

Dongre, V., Nair, N., Balwir, T., & Karlekar, B. (2025). Phosphodiesterase-5 inhibitors and testosterone in erectile dysfunction: Mechanisms, therapeutic approaches, and emerging perspectives. International Journal of Health & Allied Sciences, 14(3), 207-213. https://doi.org/10.4103/ijhas.ijhas_113_25

Vancouver

Dongre V, Nair N, Balwir T, Karlekar B. Phosphodiesterase-5 inhibitors and testosterone in erectile dysfunction: Mechanisms, therapeutic approaches, and emerging perspectives. International Journal of Health & Allied Sciences. 2025;14(3):207-213. doi:10.4103/ijhas.ijhas_113_25

BibTeX
@article{Dongre2025,
  author = {Dongre, Vaishali and Nair, Nancy and Balwir, Trupti and Karlekar, Bhagyashree},
  title = {Phosphodiesterase-5 inhibitors and testosterone in erectile dysfunction: Mechanisms, therapeutic approaches, and emerging perspectives},
  journal = {International Journal of Health & Allied Sciences},
  year = {2025},
  volume = {14},
  number = {3},
  pages = {207--213},
  doi = {10.4103/ijhas.ijhas_113_25}
}
Kostenlos starten →